EA199800729A1 - Производные ациклических нуклеозидов - Google Patents

Производные ациклических нуклеозидов

Info

Publication number
EA199800729A1
EA199800729A1 EA199800729A EA199800729A EA199800729A1 EA 199800729 A1 EA199800729 A1 EA 199800729A1 EA 199800729 A EA199800729 A EA 199800729A EA 199800729 A EA199800729 A EA 199800729A EA 199800729 A1 EA199800729 A1 EA 199800729A1
Authority
EA
Eurasian Patent Office
Prior art keywords
derivatives
radicals
acyclic nucleosides
monounsaturated
chch
Prior art date
Application number
EA199800729A
Other languages
English (en)
Other versions
EA001404B1 (ru
Inventor
Пер Энгельхардт
Марита Хегберг
Ксиао-Ксионг Жоу
Бьерн Линдборг
Нильс Гуннар Йоханссон
Original Assignee
Медивир Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9600613A external-priority patent/SE9600613D0/xx
Priority claimed from SE9600614A external-priority patent/SE9600614D0/xx
Application filed by Медивир Аб filed Critical Медивир Аб
Publication of EA199800729A1 publication Critical patent/EA199800729A1/ru
Publication of EA001404B1 publication Critical patent/EA001404B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Соединения формулы (I), в которой один из радикалов Rи Rпредставляет собой -С(О)СН(СН(СН))NHили -C(O)CH(CH(CH)CHCH)NH; другой из радикалов Rи Rпредставляет собой -С(=O)С-Снасыщенный или мононенасыщенный, необязательно замещенный алкил; а Rпредставляет собой ОН или Н; и фармацевтически приемлемые соли такого соединения находят применение в качестве антивирусных агентов с усиленной биоприменимостью против герпеса и ретровирусных инфекций.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199800729A 1996-02-16 1997-02-14 Производные ациклических нуклеозидов EA001404B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9600613A SE9600613D0 (sv) 1996-02-16 1996-02-16 Acyclic nucleoside derivatives
SE9600614A SE9600614D0 (sv) 1996-02-16 1996-02-16 Antiviral compounds
PCT/SE1997/000241 WO1997030051A1 (en) 1996-02-16 1997-02-14 Acyclic nucleoside derivatives

Publications (2)

Publication Number Publication Date
EA199800729A1 true EA199800729A1 (ru) 1999-02-25
EA001404B1 EA001404B1 (ru) 2001-02-26

Family

ID=26662518

Family Applications (2)

Application Number Title Priority Date Filing Date
EA200000787A EA002809B1 (ru) 1996-02-16 1997-02-14 Промежуточные соединения для получения ациклических нуклеозидов
EA199800729A EA001404B1 (ru) 1996-02-16 1997-02-14 Производные ациклических нуклеозидов

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA200000787A EA002809B1 (ru) 1996-02-16 1997-02-14 Промежуточные соединения для получения ациклических нуклеозидов

Country Status (26)

Country Link
US (5) US5869493A (ru)
EP (2) EP0880521B1 (ru)
JP (2) JP2000504721A (ru)
KR (1) KR100464692B1 (ru)
CN (1) CN1067073C (ru)
AR (1) AR005827A1 (ru)
AT (2) ATE231508T1 (ru)
AU (1) AU715062B2 (ru)
BG (1) BG64179B1 (ru)
CA (1) CA2243826C (ru)
CZ (1) CZ292169B6 (ru)
DE (2) DE69718619T2 (ru)
DK (1) DK0888348T3 (ru)
EA (2) EA002809B1 (ru)
ES (2) ES2189942T3 (ru)
HK (1) HK1015773A1 (ru)
HU (1) HU229865B1 (ru)
IL (1) IL124760A (ru)
MY (1) MY123083A (ru)
NO (1) NO322930B1 (ru)
NZ (1) NZ330472A (ru)
PL (1) PL184892B1 (ru)
SK (1) SK284613B6 (ru)
TR (1) TR199801318T2 (ru)
TW (1) TW533213B (ru)
WO (2) WO1997030051A1 (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
US5869493A (en) * 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
EP0942916A2 (en) * 1996-11-12 1999-09-22 Medivir Aktiebolag Nucleosides
ATE227289T1 (de) * 1997-02-10 2002-11-15 Medivir Ab Verfahren zur herstellung von azyklischen nukleosiden
US6184376B1 (en) 1997-02-10 2001-02-06 Mediver Ab Synthesis of acyclic nucleoside derivatives
JP3844654B2 (ja) * 1997-08-15 2006-11-15 メディヴィル・アクチボラグ レトロウイルス逆転写酵素およびｂ型肝炎ウイルス（ｈｂｖ）のｄｎａポリメラーゼのインヒビターを含む抗ウイルス剤などのヌクレオシドアナログ
AU1711599A (en) * 1997-12-19 1999-07-12 Bristol-Myers Squibb Company Prodrugs of lobucavir and methods of use
TW200510415A (en) * 2003-04-30 2005-03-16 Teva Pharma Process for the preparation of famciclovir
US7829548B2 (en) 2004-12-30 2010-11-09 Medivir Ab Compounds useful in the treatment of HIV
WO2006082588A2 (en) * 2005-02-07 2006-08-10 Pharmalight Inc. Method and device for ophthalmic administration of active pharmaceutical ingredients
CN101033238B (zh) * 2006-03-06 2011-02-16 中国科学院上海药物研究所 嘌呤类化合物双氨基酸酯的制备方法和用途
ZA200702234B (en) * 2006-03-21 2008-07-30 Cipla Ltd Preparation of ester of purine derivatives
MX2010000424A (es) 2007-07-09 2010-08-10 Easter Virginia Medical School Derivados de nucleosidos sustituidos con propiedades antivirales y antimicrobianas.
JP2010540440A (ja) * 2007-09-21 2010-12-24 エピファニー バイオサイエンシズ， インク． バロマシクロビル多形体
WO2011022712A1 (en) * 2009-08-21 2011-02-24 Epiphany Biosciences, Inc. Method of treating infectious mononucleosis with acylic nucleoside derivatives
SI2691530T1 (en) 2011-06-10 2018-08-31 Oregon Health & Science University CMV glycoproteins and recombinant vectors
KR101763127B1 (ko) 2015-06-23 2017-08-01 (주)농협아그로 끈끈이 엠보싱 트랩 테이프
WO2024118480A1 (en) * 2022-11-28 2024-06-06 Epiphany Biosciences Use of antiviral agents, composition of matter, combination preparations/agents to treat chronic diseases associated with epstein-barr virus and other human herpes viruses

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3116282A (en) 1960-04-27 1963-12-31 Upjohn Co Pyrimidine nucleosides and process
FR2040177A1 (en) 1969-01-31 1971-01-22 Robugen Gmbh 2-deoxyribosyl-uracil derivs
US3817982A (en) 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
US4247544A (en) 1979-07-02 1981-01-27 The Regents Of The University Of California C-5 Substituted uracil nucleosides
US4267171A (en) 1979-07-02 1981-05-12 The Regents Of The University Of California C-5 Substituted cytosine nucleosides
JPS57146798A (en) 1981-03-06 1982-09-10 Yamasa Shoyu Co Ltd Hexosyl nucleoside derivative
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
US4724232A (en) 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
EP0286825A3 (en) 1987-03-18 1989-04-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Use of 3'-fluro-3' deoxythymidine for the manufacture of a medicament for the treatment of virus infections
SE8701605D0 (sv) 1987-04-16 1987-04-16 Astra Ab Novel medicinal compounds
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.
ATE93236T1 (de) * 1987-10-28 1993-09-15 Pro Neuron Inc Acylatiertes uridin und cytidin und deren verwendungen.
SE8704298D0 (sv) 1987-11-03 1987-11-03 Astra Ab Compounds for use in therapy
US5284837A (en) 1988-05-06 1994-02-08 Medivir Ab Derivatives of purine, process for their preparation and a pharmaceutical preparation
SE8801729D0 (sv) 1988-05-06 1988-05-06 Astra Ab Purine derivatives for use in therapy
US5216141A (en) 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
SE8802173D0 (sv) 1988-06-10 1988-06-10 Astra Ab Pyrimidine derivatives
US5043339A (en) * 1988-12-19 1991-08-27 Burroughs Wellcome Co. Antiviral compounds
FI95384C (fi) 1989-04-06 1996-01-25 Squibb Bristol Myers Co Menetelmä 3'-deoksi-3'-substituoitujen metyylinukleosidien valmistamiseksi ja menetelmässä käytettäviä välituotteita
IE980216A1 (en) * 1989-04-17 2000-02-23 Scotia Holdings Plc Anti-virals
US5674869A (en) * 1990-07-07 1997-10-07 Beecham Group Plc Pharmaceutical treatment
SE9003151D0 (sv) 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
GB2260319B (en) * 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
US5874578A (en) 1992-07-13 1999-02-23 Bristol-Myers Squibb Process for preparing guanine-containing antiviral agents and purinyl salts useful in such process
GB9307043D0 (en) * 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
DE4311801A1 (de) * 1993-04-09 1994-10-13 Hoechst Ag Neue Carbonsäureester von 2-Amino-7-(1,3-dihydroxy-2-propoxymethyl)purin, deren Herstellung sowie deren Verwendung
GB9320316D0 (en) * 1993-10-01 1993-11-17 Smithkline Beecham Plc Pharmaceuticals
TW282470B (ru) * 1993-11-18 1996-08-01 Ajinomoto Kk
US5521161A (en) 1993-12-20 1996-05-28 Compagnie De Developpment Aguettant S.A. Method of treating HIV in humans by administration of ddI and hydroxycarbamide
WO1995022330A1 (en) * 1994-02-17 1995-08-24 Commonwealth Scientific And Industrial Research Organisation Antiviral agents
PE32296A1 (es) * 1994-07-28 1996-08-07 Hoffmann La Roche Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
JP3906488B2 (ja) 1995-02-21 2007-04-18 味の素株式会社 プリン誘導体の製造方法
WO1997027194A1 (en) * 1996-01-26 1997-07-31 F. Hoffmann-La Roche Ag Process for preparing purine derivatives
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
ES2180923T5 (es) * 1996-01-26 2005-10-16 F. Hoffmann-La Roche Ag Proceso para la preparacion de derivados de purina.
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US6703394B2 (en) * 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
EP0827960A1 (en) 1996-09-10 1998-03-11 Ajinomoto Co., Inc. Process for producing purine derivatives

Also Published As

Publication number Publication date
US5869493A (en) 1999-02-09
DE69718626T2 (de) 2003-09-11
HUP9900680A3 (en) 2001-02-28
MY123083A (en) 2006-05-31
ES2189941T3 (es) 2003-07-16
TW533213B (en) 2003-05-21
JP2000504721A (ja) 2000-04-18
JP4171069B2 (ja) 2008-10-22
AU713916B2 (en) 1999-12-16
ATE231507T1 (de) 2003-02-15
WO1997030052A1 (en) 1997-08-21
BG102647A (en) 1999-04-30
PL328335A1 (en) 1999-01-18
KR19990082571A (ko) 1999-11-25
PL184892B1 (pl) 2003-01-31
EA002809B1 (ru) 2002-10-31
AU715062B2 (en) 2000-01-13
CZ292169B6 (cs) 2003-08-13
DE69718626D1 (de) 2003-02-27
US20120123119A1 (en) 2012-05-17
CA2243826A1 (en) 1997-08-21
EP0880521B1 (en) 2003-01-22
HK1015773A1 (en) 1999-10-22
WO1997030051A1 (en) 1997-08-21
HUP9900680A2 (hu) 1999-06-28
EP0880521A1 (en) 1998-12-02
US6576763B1 (en) 2003-06-10
CA2243826C (en) 2005-12-27
BG64179B1 (bg) 2004-03-31
JP2000504720A (ja) 2000-04-18
AR005827A1 (es) 1999-07-14
EA001404B1 (ru) 2001-02-26
KR100464692B1 (ko) 2005-06-21
EA200000787A1 (ru) 2001-04-23
CN1067073C (zh) 2001-06-13
DE69718619T2 (de) 2003-08-21
EP0888348B1 (en) 2003-01-22
US8124609B2 (en) 2012-02-28
CZ232298A3 (cs) 1998-10-14
TR199801318T2 (xx) 1998-10-21
NO322930B1 (no) 2006-12-18
SK284613B6 (sk) 2005-07-01
ES2189942T3 (es) 2003-07-16
US20090076041A1 (en) 2009-03-19
CN1210537A (zh) 1999-03-10
NZ330472A (en) 2000-02-28
US6255312B1 (en) 2001-07-03
DK0888348T3 (da) 2003-04-14
EP0888348A1 (en) 1999-01-07
AU1818297A (en) 1997-09-02
ATE231508T1 (de) 2003-02-15
NO983216L (no) 1998-10-13
IL124760A (en) 2003-09-17
DE69718619D1 (de) 2003-02-27
IL124760A0 (en) 1999-01-26
HU229865B1 (en) 2014-10-28
NO983216D0 (no) 1998-07-13
AU1818397A (en) 1997-09-02
SK98598A3 (en) 1998-12-02

Similar Documents

Publication Publication Date Title
EA199800729A1 (ru) Производные ациклических нуклеозидов
EA199900166A1 (ru) Замещенные 6,6-гетеробициклические производные
FI933568A (fi) 9-((substituerad glycyl)amido)-6-demetyl-6-deoxitetracykliner
FI933565A (fi) 7-(substituerad)-9-((substituerad glycyl)amido)-6-demetyl-6-deoxitetracykliner
EA200100229A1 (ru) Пептидные ингибиторы вируса гепатита с
EA199900083A1 (ru) Замещенные пиридо- или пиримидосодержащие 6,6 или 6,7-бициклические производные
EA200100983A1 (ru) Производные 13-метилэритромицина
ES2171428T3 (es) Derivados de galantamina, un procedimiento para su preparacion y su uso como medicamentos.
EA199900163A1 (ru) Акрилоил-замещенные производные дистамицина, способы их получения и их применение в качестве противоопухолевых и противовирусных средств
DE69505470D1 (de) Pyrrolocarbazol
SE8604950L (sv) Demensforbettrande och terapeutiska medel
EA199801013A1 (ru) Производные дистамицина, способ их получения и применение в качестве противоопухолевых и противовирусных агентов
DK0399519T3 (da) Potensering af celleformidlet immunitet under anvendelse af polyaminderivater
DK640687D0 (da) Allylmercaptoacetylsydnoniminer, deres fremstilling og anvendelse
ES2072765T3 (es) Procedimiento para la obtencion de 5,6-dihidroxi-indolinas.
HU9600996D0 (en) Nitric esters from derivatives of 2-(2,6-dihalophenyl-amino)-phenylacetoxyacetic acid and their preparation procedures
PT96757A (pt) Processo de preparacao de derivados de indolo e de composicoes farmaceuticas
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
DK0417746T3 (da) N-Azabicyclo(3.3.0)octanamider af aromatiske syrer
ES2058729T3 (es) Derivados de pradimicina.
BR9200156A (pt) Formulacoes-aquosas,estaveis e homogeneas-de tenso-ativos e processo para a sua obtencao
ES2186127T3 (es) Sintesis de derivados de nucleosidos aciclicos.
EA199800929A1 (ru) Фунгицидные смеси
BR9406996A (pt) Enanciômero processo para preparar o mesmo processo para ciclizar um composto e composto intermediário
PT92175A (pt) Processo para a preparacao de 3-amino-sidnoniminas substituidas e de produtos intermediarios farmacologicamente activos

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU